Showing results (111-120 of 181) with videos related to

Sort By:
Pageof 19
Transplantation|April 1, 2011
Factors increasing quantitative interstitial fibrosis from 0 hr to 1 year in living kidney transplant patients receiving tacrolimusYoshiko Miura, Shigeru Satoh, Mitsuru Saito, et al.
Cancer Diagnosis & Prognosis|January 5, 2026
Comparison of IO-IO and IO-TKI Treatment Outcomes in Metastatic Renal Cell Carcinoma: Influence of Metastatic Site CountHiroshi Kikuchi, Takahiro Osawa, Sei Naito, et al.
BMC Urology|May 10, 2018
Impact of early changes in serum biomarkers following androgen deprivation therapy on clinical outcomes in metastatic hormone-sensitive prostate cancerHiromi Sato, Shintaro Narita, Norihiko Tsuchiya, et al.
Urology|December 3, 2014
Renal subcapsular fluid collection caused by penetration of a pancreatic pseudocystSoki Kashima, Takamitsu Inoue, Mitsuru Chiba, et al.
The Prostate|December 13, 2025
Androgen-Deprivation Therapy and Dietary Habits Influence the Gut Microbial Environment in Patients With High-Risk Localized Prostate CancerMasanori Ishida, Shintaro Narita, Hiromi Sato, et al.
Hinyokika Kiyo. Acta Urologica Japonica|September 7, 2022
[A Case of Renal Anastomosing Hemangioma]Yoshiki Sasaki, Soki Kashima, Takashi Koyama, et al.
Clinical Genitourinary Cancer|August 17, 2019
Validation of the IMDC Prognostic Model in Patients With Metastatic Renal-Cell Carcinoma Treated With First-Line Axitinib: A Multicenter Retrospective StudySakae Konishi, Shingo Hatakeyama, Kazuyuki Numakura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 26, 2025
Outcomes of Nivolumab-Plus-Ipilimumab in Metastatic Renal Cell Carcinoma: Second Interim Analysis of the J-ENCORE StudyTomokazu Sazuka, Katsunori Tatsugami, Suguru Shirotake, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 15, 2025
Expression of Glucocorticoid Receptor Beta in Bladder Cancer and Its Clinicopathological Significance: A Novel Diagnostic Marker to Predict Progression and Recurrence of CancerTakashi Kukimoto, Yasuhiro Nakamura, Shuko Hata, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 17, 2026
A Minimum 3-Year Follow-Up of Nivolumab-Plus-Ipilimumab in Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma: A Final Analysis of the J-ENCORE StudyShuzo Hamamoto, Masahiro Nozawa, Suguru Shirotake, et al.
Pageof 19